top of page

ABOUT US

We see a world of

POTENTIAL

in every person

       including those with rare diseases. 

 

We believe that treatments for rare diseases are as valuable as those for more common illnesses.

 

Tern Therapeutics was founded with a new vision for speeding the development of transformative, one-time genetic treatments for rare diseases.  

Our Values

Patients and their families are at the core of everything we do. Tern Therapeutics is committed to integrity, empathy, urgency, innovation, and determination as we work in partnership with patient communities at every stage of development to deliver treatments to those living around the world with rare diseases. 

URGENCY

We act with urgency, recognizing that every moment counts for the children and families awaiting new treatment options.

INNOVATION

We are dedicated to relentless scientific, regulatory, and commercial innovation with the goal of delivering our cutting-edge treatments to patients as      efficiently as possible.

INTEGRITY

We uphold the highest standards of integrity in our approach to drug development and interactions with patients and their families.

EMPATHY

We embody empathy and prioritize compassion, centering our work on the needs of patients and their families.

DETERMINATION

We are determined to overcome challenges, persevere through difficulties, and deliver on our promise to improve the lives of patients living with rare diseases.

Family iconAsset 2_300x-100_edited.jpg

Leadership Team

Alex M. Bailey, PhD
Chief Executive Officer
Christina M. Ohnsman, MD
Chief Medical Officer
Matthew Rosini
Chief Financial and Administrative Officer

Our name was inspired by the strength and determination of the Arctic tern, a small, fast, tenacious bird that migrates from the Arctic to the Antarctic and back every year, the longest migration of any animal on the planet.  We resolve to go to the ends of the earth to fulfill our mission of speeding the development of transformative, one-time genetic treatments to unlock the full potential of children living with rare diseases.

bottom of page